You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (43) |
Back to Search
Taiwan: the censoring and monitoring mechanism about the change of appearance of drug and package in taiwan.
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-CPS-100
- By: TANG, Tzung Han (Community pharmacy, Taichung, China Taiwan)
- Co-author(s): Tzung Han Tang
- Abstract:
Background
some people make fake medicine sell to pharmacy and clinics in March 2017 in Taiwan. They used cheaper hypolipidemic drugs substituted for the more expensive kind. Taiwan's Food and Drug Administration (TFDA) was first alerted by a pharmacist that a batch of rosuvastatin, or marketed as Crestor®, manufactured by global biotechnology.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026